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1. Introduction 
Quantum dots (QDs) are colloidal semiconductor nanocrystals which have unique optical 
properties due to their three dimensional quantum confinement regime. The quantum 
confinement may be explained as follows: in a semiconductor bulk material the valence and 
conduction band are separated by a band gap (Eg). After light absorption, an electron (e-) 
can be excited from the valence band to the conduction band, leaving a hole (h+) in the 
valence band. When the electron returns to the valence band, fluorescence is emitted. 
During the small time scale of the light absorption the e- and h+ perceive one another and do 
not move so independently due to Coulomb attraction (Brus, 1984). The e-- h+ pair may be 
observed as an Hydrogen-like species called exciton and the distance between them is called 
the exciton Bohr radius (aB). When the three dimensions of the semiconductor material are 
reduced to few nanometers and the particles become smaller than the Bohr radius, one can 
say that they are in quantum confinement regimen and in this situation these nanoparticles 
are named quantum dots (QDs). For example, the exciton Bohr radius of CdS and CdSe bulk 
materials presents a size of aB = 3 to 5 nm.  
In this way, QDs can be defined as colloidal particles made of semiconductor materials with 
diameters ranging typically from 2 to 10 nm. The semiconductor particle (named “core”) is 
usually coated by a layer of another semiconductor material (named “shell”) which in 
general has a greater band gap than the band gap of the core rendering excellent optical 
properties. The QDs’ core is responsible for the fundamental optical properties (i.e. light 
absorption and emission) and the shell is used to passivate the surface of the core with the 
goal to improve its optical properties and reduce chemical attack. The shell separates 
physically the optically active core from its surrounding medium (Dabbousi et al., 1997; 
Santos et al., 2008a) as depicted in Figure 1. As a consequence, the nanoparticles’ optical 
properties become less sensitivity to changes induced, for example, by the presence of 
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oxygen or pH in the local environment. At the same time, the shell reduces the number of 
surface dangling bonds, which can act as trap states for electrons and minimize the QDs 
fluorescence efficiency. 
 
Figure 1. A schematic representation of a functionalized core-shell quantum dot bound to a biomolecule. 
For biomedical purposes, in which fluorescence in the visible region is usually required, 
both core and shell are composed of elements from the II B and VI A groups of the Periodic 
Table. The major examples are CdSe/ZnS, CdTe/CdS and ZnSe/ZnS QDs (Dabbousi et al., 
1997; Santos et al., 2008a). Most QDs crystallize either in the cubic zinc blend or in the 
hexagonal wurtzite type structure (Yeh et al., 1992). 
In nanosized regime many QDs’ physico-chemical properties are different from those of the 
same bulk materials. Since QDs are fluorescent nanoparticles, an example of these changes 
is the shift of the emission color according to the particle size. In this case, QDs made from 
the same material, but with different sizes, can present fluorescence light emission in 
different spectral regions (from the ultraviolet to the infrared light) as represented in Figure 
2. This is a consequence of QDs energy level discretization and also of the QDs band gap 
energy changes according to their size. After absorption, electrons come back to valence 
band and QDs emission is proportional to the band gap energy. As smaller the QDs are, the 
higher is the band gap energy and more towards to the blue end is the emission (since the 
energy is inversely proportional to the wavelength of the light).  
Another observed feature for these systems is that the QDs’ absorption bands are broad and 
extend up to the UV region, as observed in Figure 3 (A). The first peak (located at greater 
wavelength) represents an exciton formed by transitions between discrete states. The width 
of the first absorption band is related to the size dispersion of the nanoparticles and can give 
us information about the QDs’ average size and nanoparticles concentration (Santos et al., 
2008a). On the other hand, the width of the emission spectrum is related to the presence of 
crystal defects which result in discreet electronic states between the conduction and the 
valence band. These new electronic states displace the emission towards to the red and 
broaden the emission band and is related to the passivation shell.  
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Figure 2. Emission spectra as a function of size for the same quantum dot material. The colored spheres 
represent the size decrease of the particles. 
 
Figure 3. Characteristic absorption and emission band profile of (A) QDs colloidal suspension (A) and 
(B) a typical organic fluorophore (B). 
The QDs’ physico-chemical properties have offered considerable advantages and 
complementary characteristics over the conventional fluorescent dyes. Besides the size 
tunable emission discussed before, compared to organic fluorophores, the major advantages 
offered by QDs are:  
1. A broad absorption band (Fig. 3A), allowing a flexible cross section for multiphoton 
microscopy and as well as for Fluorescence Energy Transfer (FRET) processes (Fig. 3A 
and B compare the characteristic absorption and emission band profiles of QDs and 
organic fluorophores). 
2. An active surface for chemical conjugation. QDs can be conjugated to a variety of 
proteins or antibodies and become inorganic-biological hybrids nanoparticles that 
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combine characteristics of both materials, that is, the fluorescence properties of QDs 
with the biochemical functions of the attached biomolecules (Fig. 1). 
3. High resistance to photobleaching: the most important advantage of QDs over organic 
dyes allowing long term observation of these fluorescent nano-probes. 
Colloidal QDs can be synthesized in organic or aqueous medium. When compared to 
organometallic routes, water-based QDs syntheses are cheaper, less toxic and intrinsically 
biocompatible to applications in biomedical fields (Santos et al., 2008a). The colloidal 
synthesis generally involves several consecutive stages: (i) nucleation from an initially 
homogeneous solution, (ii) growth of the preformed crystal nuclei into isolated particles, 
reaching the desired size from the reaction mixture and (iii) post preparative treatments, 
such as colloidal purification, size precipitation and UV light exposure. 
During the colloidal synthesis QDs end up coated by organic or inorganic molecules (called 
surfactants or stabilizers), which keep the nanocrystals away from each other preventing 
agglomeration and precipitation (Brus, 1984; Santos et al., 2008a) (Figure 1). In some cases, as 
for CdTe QDs for example, the surfactant molecules may also act as precursors of the 
passivation shell (Menezes et al., 2005). For the direct aqueous synthetic procedures the main 
classes of organic molecules used as surfactants are alkyl-thiol molecules such as 
mercaptopropionic acid - MPA, mercaptoacetic acid - MAA and mercaptosuccinic acid – 
MSA, Dihydrolipoic acid – DHLA, cysteine – CYS, cysteamine – CYSAM and different 
mercaptodithiols. The carboxyl, thiol or amine terminals of these molecules can be used as 
chemical bridges to conjugate biomolecules (such as proteins and biopolymers) which 
confer more specificity for biological applications. The chemical binding of such 
biomolecules to the surface of the QDs is a process defined as bioconjugation. It can be 
accomplished by simple adsorption (of stabilizing agent such as: MPA, MSA or cysteine) to 
the biomolecule or by covalent attachment. Currently, bioconjugation occurs between 
carboxyl-amine (through EDC and Sulfo-NHS) groups, amine-amine (by glutaraldehyde), 
disulfide bonds and streptavidin-biotin interactions (Goldman et al., 2002). 
For the non-aqueous synthetic routes, nucleation and growth of QDs occur in the solution 
phase in the presence of organic surfactant molecules, which dynamically adhere to the 
surface of growing crystals. Typical surfactants include long-chain carboxylic and 
phosphonic acids (e.g., oleic acid and n-octadecylphosphonic acid), alkanethiols (e.g., 
dodecanethiol), alkyl phosphines, alkylphosphine oxides (classical examples are 
trioctylphosphine, TOP, and trioctylphosphine oxide, TOPO), and alkylamines such as 
hexadecylamine (Yin & Alivisatos, 2005). In order to be applied to biological systems as 
active fluorophores these nanocrystals must be extracted from the organic phase to an 
aqueous phase. An alternative method of dispersing non-aqueous QDs is to form a 
hydrophilic coating that carries along with it a layer of hydration consisting of hydrogen-
bonded water molecules. This often is accomplished by using hydroxyl bearing polymers or 
Polyethylene glycol (PEG) modifications. These also prevent aggregation due to the high 
energy needed to remove the bound water layer. 
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2. Applications of quantum dots in biomedical sciences 
Since the first mention in the literature, in 1998, QDs have been studied extensively and the 
applications of these fluorescent nanocrystals range from imaging fixed and live cells all the 
way to fluoroimmunoassays rendering innovative diagnostic methodologies (Bruchez Jr. et al., 
1998; Chan & Nie, 1998). QDs have been used in many different studies, such as a probe in 
DNA hybridization, in receptor mediated endocytosis, monitoring of parasite metabolism and 
visualization of tissue and cellular structures in real time. Due to their photostability and low 
cytotoxicity the QDs are starting to be used as fluorophores for in vivo applications, but there is 
still a great discussion about their safe use. When injected in the initial stage of embryonic 
development of Xenopus embrios, for instance, the QDs demonstrated to be stable, non-toxic 
and resistant to photobleaching (Dubertret et al., 2002). This experiment also showed its 
potential in monitoring the development and cellular differentiation processes that occur 
during embryogenesis. The use of QDs as fluorophores is important for the real time diagnosis 
of tumors. Preliminary experiments with QDs emitting in the near infrared conducted in 
animals have shown promising results in the sensitive detection of cancerous tumors and in 
vivo systems (Cai et al., 2006; Gao et al., 2010). The prospects of the applications of QDs, 
especially those free of heavy metals such as zinc based QDs, make them even more promising 
for its current use in the near future. Moreover, cells labeled with QDs can be injected in small 
animals and the fluorescence can be used to follow a particular pathway in the organism, such 
as the carcinogenesis process, helping to understand the process and discover new kinds of 
treatments (Noh et al., 2008). 
2.1. Quantum dots as fluorophores for imaging and detection purposes 
2.1.1. Non-specific labeling  
The staining of a biological sample can occur even when the reporting probe is not designed 
to interact with a specific molecule. Untargeted labeling of the probe with the (biological) 
material is defined as a non-specific interaction, and can be usually mediated by hydrophobic 
and/or electrostatic interactions between the surface molecules of the particles with 
molecules in suspension or on the anchoring surface such as cellular plasma membrane or 
even by internalization process (Biju et al., 2010).  
In the past years, when the use of QDs in biomedical research was still at the beginning, 
passive labeling (simple staining of biological samples) was of great interest since researchers 
aimed to study the probe itself as a potential dye. In such applications, labeling could give 
information about bioavailability and more importantly about the optical properties of these 
nanoparticles in biological conditions. It has been shown that the simple incubation with a 
biological specimen may have the potential to stain it, revealing its structural features or even 
their biological behavior. We observed this feature for instance in the non-targeted 
glutaraldehyde-capped CdS/Cd(OH)2 QDs staining of different neural cell lines, normal and 
cancerous cells (Santos et al., 2008b) as demonstrated in the staining pattern observed in 
Figure 4 (A – D). For these systems the unrestricted labeling/internalization allows the 
identification of minor details of the cellular architecture, such as cell-cell contacts, axons and 
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intracellular organelles, as shown on the images of Fig. 4A and Fig. 4B. Moreover, these QDs 
are taken up at different rates depending on cellular stage as for normal glial or glioblastoma 
cells (Farias et al., 2006) – Figures 4C and 4D, respectively. Therefore, passive labeling can be a 
useful strategy when one aims to label the whole biological sample or to study differences in 
the behavior of normal versus cancer cells in diagnostic purposes. 
2.1.2. Internalization of quantum dots by live cells 
In general, the binding of non-targeted particles with living cells results in internalization of 
the particles. This process may be accomplished by different routes, which depend either on 
the particle properties (size, shape, surface functionalization, surface charge and the 
combination of these properties) or on the cell type (i.e. lineage, metabolic state, cell cycle 
stage, normal or cancerous cells). The first assumption was that the main internalization 
process resulted from endocytosis. One of the first reports to show that internalization of 
these nanoparticles occurs by endocytosis was described by Jaiswal et al. (Jaiswal et al., 
2003), where human cancer (HeLa) cells and Dictyostelium discoideum amoeba cells 
internalize negatively-charged DHLA-capped QDs, a process inhibited by low temperature 
treatment and co-localized with endosome markers.  
 
Figure 4. Non-targeted glutaraldehyde-capped CdS/Cd(OH)2 labeling of live neuron live cells (A) and live 
glioblastoma cells (B). It is possible to observe the cell body and axons in living neurons and intravesicular 
structures in glioblastomas. Intensity map images of glial (C) and glioblastomas (D) incubated for three 
minutes with these QDs. Insets are the corresponding fluorescence images. (Santos et al., 2008a). 
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Molecule specific endocytosis is known as receptor-mediated endocytosis which are clathrin or 
caveolae-mediated endocytosis, or clathrin/caveolae independent endocytosis. It is probably 
the major pathway where QDs are uptaken by cells. It seems that lipid rafts localized within 
the plasma membrane plays an important role in the QDs uptake as well. These rafts provide a 
support for the assembly of many receptors, adaptors as well as proteins involved in a 
signaling complex such as caveolae and clathrin. (Nichols, 2003a; Nichols 2003b) 
In 2011, Maysinger and collaborators synthesized QDs with almost the same hydrodynamic 
size (between 8-10 nm) and functionalized with different short ligands such as cysteine, 
cysteamine, dihydrolipoic acid and mercaptopropionic acid (Al-Hajaj et al, 2011). These QDs 
were tested in human embryonic kidney cells (Hek 293) and human heptocellular carcinoma 
cells (Hep G2) in order to achieve information about these QDs uptake and elimination. 
They showed that most of the QDs with the same size but different surface properties were 
uptaken through lipid raft-mediated endocytosis with the contribution of the XAG transport 
system (responsible for the carrier-mediated Na(+)-independent transport of anionic amino 
acids such as glutamate and aspartate across the plasma membrane of cells) which takes up 
cysteine, glutamate and aspartate. The contribution of a P-glycoprotein transporter on QD 
efflux was also demonstrated during the experiments. Figure 5 shows the hypotheses about 
QDs internalization and elimination. 
 
Figure 5. Representation of all the cell signaling mechanisms Studied by using QDs (Al-Hajaj et al, 2011). 
These results corroborated with those obtained from Chan’s (Jiang et al., 2008), where they 
showed the size dependent internalization of particles using both pathways clathrin- and 
caveolae- mediated endocytosis. It has been shown that particles with a diameter of d = 40 - 
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50 nm are endocytosed more efficiently than those larger or smaller (Jiang et al., 2008). Sizes 
also dictates the final location of the particles (i.e. cytosol, nucleus), being able or not to cross 
their natural cellular barriers (Williams et al., 2009), which is on the other hand cell-type 
dependent (Williams et al., 2009). 
However, QDs internalization by cells not only depends on their size. Although size is an 
important parameter, charge is thought as one of the most important parameter controlling 
cell-QD interactions (Conroy et al., 2008). An interesting finding of charge-mediated 
internalization and interactions with intracellular structures was found by Conroy et. al. 
(Conroy et al., 2008), who demonstrated that these carboxyl-coated (negative) QDs but not 
amine-coated (positive) are able to enter macrophage-like cells and bound nuclear structures 
rich in the positive histone proteins. In fact, such interactions were sufficiently strong to 
change QDs’ optical and colloidal properties even in cell-free conditions (Conroy et al., 2008). 
Lira et al have recently shown that even in the same cell population, carboxyl-coated QDs 
have differential access to intracellular compartments and when they reach the nucleus, they 
actually bind nuclear/nucleolar structures, as shown in Figure 6 for permeabilized human-
derived peripheral blood cells (Lira et al., 2012). Figure 6 shows that the intracellular 
localization of these carboxyl-QDs for same cell population may differ from cell to cell. 
Depending on the cell, QDs could or not reach the nucleus (square 1 and 2, respectively). As 
will be discussed, the surface charge plays a critical role on such interactions. Although the 
internalization efficiency is significantly higher for positively-charged materials due to the  
 
Figure 6. Non-specific labeling of fixed peripheral blood mononuclear cells. The image shows an 
optical field where CdTe/CdS QDs can reach only the cytoplasm (square 2) or can cross the nuclear 
membrane and reach the nucleus (square 1). In the nucleus, these nanoparticles bind with high affinity 
nuclear structures such as nucleoli (Lira et al., 2012).  
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Figure 7. Human mammary tissue diagnosed as Fibroadenoma (Fib). (A1) Fib treated with Evan’s Blue 
solution (EB); (B1) Fib incubated with QDs diluted in EB (QD-FIB-EB); (C1) Fib incubated with QD-Con-
A conjugate diluted in EB (QD-Con-A-FIB-EB). A2, B2 and C2 are the intensity maps of A1, B1 and C1, 
respectively. The bright pattern observed in (1c) is related to regions of high glucose/mannose 
expression in the tissue (Santos et al., 2006). 
interactions with the negative cell surface, it is believed that cationic sites on the negatively 
charged cell surface can mediate the interaction of negative nanomaterials (Ghinea et al., 
2009) eventually leading to internalization by cells.  
2.1.3. Some examples of specific labeling  
The capacity of QDs for specific labeling cells and tissues depends on the bioconjugation. 
Santos et al., for example, reported the use of CdS/Cd(OH)2 QDs functionalized with 
glutaraldehyde and conjugated to concanavalin-A (Con-A) lectin (Santos et al., 2006) to 
investigate cell alterations regarding carbohydrate profile in human mammary tissues 
diagnosed as fibroadenoma (benigne tumor). Con-A lectin is a protein which binds 
specifically to glucose/mannose residues expressed in the plasma membrane. Figure 7 shows 
the QD-Con-A more expressive staining of mammary tissue diagnosed with Fibroadenoma 
Con-A was used also in another work for cellular labeling of Candida albicans with CdTe/CdS 
QDs conjugated or not to Con-A (Kato et al., 2012). Fluorescence microscopy analysis of the 
yeast cells showed that the non-functionalized QDs do not label C. albicans cells, however for 
the QD conjugated to Con-A the cells showed a fluorescence profile indicating that the cell 
wall was preferentially marked. 
A1 B1 C1 
A2 
B2 C2 
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In another work of the same group it was also used CdS/Cd(OH)2 QDs functionalized with 
glutaraldehyde as efficient fluorescent labels for living human red blood cells (Santos et al., 
2008a), the aim of this investigation was to determine the antigen-A expression in subgroups 
of group A erythrocytes.  
 
Figure 8. Microscopic confocal images obtained for QDs/anti-A marking living A+ erythrocytes. A is 
the DIC observation of the marked red blood cells and (B) is the marking pattern when excited at 488 
nm (Santos et al., 2008a). 
2.1.4. Quantum dots for intracellular delivery 
QDs can be used as a probe for monitoring protein dynamics in live cells, allowing the study 
of their traffic down to a single molecule (Pinaud et al., 2010), taking advantages of the most 
striking properties as a fluorescent probe, which is long term imaging for prolonged periods 
of time (Courty et al., 2006). However, traffic of molecular dynamics, especially in live cells, 
are almost exclusively carried out for surface molecules – membrane proteins, accessible by 
the external side of the cells. This limitation arise mainly due to the incapacity of water 
dispersed QDs to cross the lipid bilayers by simple diffusion (only few works report 
tracking of intracellular molecules) (Chen & Gerion, 2004).  
a. Physical methods 
The physical methods to deliver aqueous compounds into cells are of special interest since the 
precise control over the cell (extent of delivery over the population) and the amount of materials 
can be reached in most cases. These are mainly based on microinjection and electroporation. In 
fact these two traditional and well recognized methods are among the most efficient methods 
to deliver QDs into cells. The electroporation is based on the application of one or more strong 
electrical pulses, which is thought to create localized pores in the membrane bilayer for 
enhancing its permeability – Figure 9A. Using electroporation, Chen and Gerion delivered 
QDs into HeLa cells (Chen & Gerion, 2004). The QDs were able to be recognized by the cellular 
machinery and enter the cell nucleus in living cells, although in a fraction of the total number 
of cells and as agglomerated particles. In fact, nanoparticle aggregates of up to 500 nm have 
been reported to be produced later after the application of electric pulses, even for protein-
A 
B 
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conjugated QDs. However, if agglomeration does not matter, as in the case of simple cell 
labeling, electroporation can be well suited. In fact, cells filled with QDs after electroporation 
can be readily seen in living mice for cell tracking purposes (Yoo et al., 2010).  
Figure 9 shows schematic representations of the most common strategies for intracellular 
delivery of membrane-impermeable materials. Figure 9A and B represent physical processes 
while Fig. 9C and D are chemical methods. In electroporation, cells are exposed to an electric 
field and a single or multiple pulses are applied, creating pores that allow the passage of 
materials to the cell interior. In the microinjection (Figure 9B), a micropipette delivers 
precise amounts of fluids inside any compartment of the cells. In Fig. 9C, the conjugation of 
QDs with Cell Penetrating Peptides (CPPs) (discussed later) can deliver them into cells by 
direct membrane entrance (as shown in the scheme of Figure 9C) or by endocytosis. Also by 
endocytosis, polycation-coated QDs (green spheres) trigger “proton-sponge effect”, 
(discussed later) releasing endo/lysosomal content into the cytosol. In Figure 9D, binding of 
negative cargos to lipoplex systems results in endocystosis likely due to charge interactions 
with negative plasma membrane. After internalization, charge neutralization seems to 
release the cargo from the lipid system.  
 
Figure 9. Schematic representations of four types of processes used in the internalization of QDs: 
electroporation (A); microinjection (B); CPP and polycation-mediated internalization (C) and lipoplex 
mediated process (D).  
Another physical method for intracellular delivery of membrane impermeable materials is 
microinjection. This technique is based on the insertion of precise volumes inside an aqueous 
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compartment (such a cell) by micropipettes – Figure 9B. Since the first attempts of using QDs 
as fluorescent probes, microinjection is recognized as a potent method to insert these particles 
in intracellular media. One example of the application of microinjection it is the use of 
micelle-capped QDs as an agent to follow the development of tissues derived from a single 
cell in living Xenopus embrios after transfection (Dubertret et al., 2002) or dynamics changes 
during the vasculature development in Zebrafish (Rieger et al., 2005). 
Although their recognized efficiency, both methods suffer from some drawbacks. 
Electroporation not only cause QDs to aggregate, but may seriously compromise cellular 
viability. On the other hand, microinjection is technically and costly demanding, requiring 
specialized equipment and, as a serial technique it has poor statistical significance. 
b. Chemical methods 
Chemical approaches represent a wealthy range of strategies for intracellular delivery of 
membrane impermeable materials, and include covering cargos’ surface or couple/bind them 
to a vehicle, promoting the labels enter into cytoplasm of a large number of cells 
simultaneously in a straightforward way. Moreover, it can actually be used in living animals - 
the methods described above can only be used in such applications in very specific conditions. 
Many methods to allow QDs to reach the cell cytosol are based on the conjugation of surface 
of nanoparticles to interact or to be recognized by cells until they reach the cytoplasm by 
different means. One of the most effective chemical methods for nanoparticle delivery into 
cells is the conjugation with Cell Penetrating Peptides (CPPs). A number of publications 
report such a class of molecules for this purpose, in which the mechanism of cell entry is 
similar to endocytosis (Thorén et al., 2004) rather than direct bypass through the lipid 
bilayer, although the consensus for the real pathway is still controversial. If trafficked into 
cells by endocytosis, these QDs bioconjugates need to be released from endo/lysosomal 
compartments to reach their targets (if such target is some intracellular organelles, for 
example).  
A wide range of molecules can be conjugated to QDs’ surface to be specifically delivered to 
cells (toxins, sugars, polymers and so on); however most of them lead to receptor-mediated 
endocytosis, which predominantly result in entrapment into endocytic vesicles. For this 
reason, we will not address here intracellular delivery of QDs by molecules which do not 
explicitly release these particles freely in cytosol. 
Other chemical modifications can result in intracellular release after nanoparticle endocytosis 
rather than simple membrane permeation – as proposed for CPPs. One of such approaches is 
to cover QDs’ surface with osmotic active polymers such as polyethyleneimine. After 
endocytosis, such polycations are capable of sequestering protons by H+-pumps in the 
endo/lysosomal membrane, which in turn force the entrance of Cl- ions and water to balance 
osmotic effects (this is the reason why this approach is called the “proton-sponge effect”). As 
a consequence, it leads vesicle rupture and releases endocytosed materials into the cell 
cytosol. Using this approach, Yezhelyev et al. delivered siRNA conjugated-QDs to breast 
cancer cells (Yezhelyev et al., 2008). The functionality of the system was showed by a 
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remarked reduction in cyclophilin B protein expression after gene silencing. One similar 
approach is the osmotic lysis, where endo/lysosomal vesicles are also ruptured, now by 
submitting cells to hypotonic solutions. In fact, it was the method used to track for the first 
time an intracellular protein in living cells using QDs (Courty et al., 2006) where kinesin from 
Drosophila were delivered and tracked in HeLa cells. Lately, Nelson et al. reported a detailed 
study on the movement of Myosin Va (a molecular motor which tracks over actin filaments) 
inside COS-7 cells (Nelson et al., 2009). However, lysosome lysis might be harmful to cells as 
some acidic proteins such as proteases are released in the cytosol, which may degrade the 
constituents in there.  
c. Quantum dots encapsulation 
Quantum Dots can be entrapped in a vehicle for its delivery instead of being conjugated to 
transporter molecules, a strategy that can be also suited for intracellular delivery after endocytic 
uptake. It is quite advantageous because it allows the conjugation of targeting moieties (i.e. 
antibodies, ligands) on the surface of the nanoparticles, which was otherwise occupied by the 
targeting transporter molecules (as in the case of CPPs peptides and polymers). Moreover, it 
can avoid the rupture of acidic intracellular vesicles, which has the tendency to cause 
cytotoxicity effects. The encapsulating vehicles can be classified in two major groups, named 
polymeric and lipid delivering systems. QDs were encapsulated in functionalized polymeric 
poly(lactic-co-glycolic acid) (PLGA) nanospheres and delivered into the cell cytosol after 
endocytosis of the complex (Kim et al., 2008). After preferential endocytosis of antibody-coated 
polymer nanospheres into ErbB2 over expressing cancer cells, the polymer were degraded in 
the acidic intracellular compartments releasing the bioconjugated QDs, which in turn could 
reach and label intracellular structures such as mitochondria and actin filaments. 
Another approach is using micelles. An advantage of encapsulating QDs in lipid micelles 
relies on the small size of the resulting probe, up to 25 nm (Carion et al., 2007). Taking 
advantages on the physical-chemical and photostability of these QD-containing micelles, the 
group who reported this system for the first time could track cell lineage developments in 
live Xenopus embrios (Dubertret et al., 2002). This breakthrough report was one of the first 
reports on the use of QDs for in vivo imaging. 
Among the vehicles composed of lipids, probably the most popular is liposomes 
(Valenzuela, 2007; Al-Jamal & Kostarelos, 2007). Liposomes are lipid vesicles containing one 
(or more) lipid bilayer(s) enclosuring an aqueous compartment and that can entrap 
hydrophilic and/or hydrophobic materials during its formation (Valenzuela, 2007). As in the 
case of micelles (or any other encapsulation system), their interaction with biological species 
depends on the physical-chemical properties, which can be fine-tuned. In fact, Yang et al. 
(Yang et al., 2009) encapsulated water aqueous CdTe QDs in folate-conjugated liposomes 
and showed that these vesicles can be directed to folate-overexpressing cancer cells and be 
monitored by QDs fluorescence. The resulting system is resistant to optical and chemical 
degradation, with lower toxic effects. 
QDs can also be delivered to cells by commercial cationic liposomes, the lipofection system 
(Fig. 9D). Lipoplex are positively-charged lipidic vesicles (mainly liposomes) able to bind 
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negative particles, including oligonucleotides and QDs, which mediate charge interactions 
with cells, leading to endocytosis of the resulting system and eventually the release of 
cargos inside the cell. In such an application, Yoo et al. (Yoo et al., 2008) reported for the first 
time the use of these lipid vesicles as QD vehicles for protein tracking inside living cells. In 
contrast to earlier works, their bioconjugated QDs could escape from cellular vesicles and 
reach the cytosol, where they could be used to track the movements of actin, kinesin and 
tubulin proteins. Although the mechanism of endossomal release of materials delivered by 
cationic liposomes is not known, it is believed that charges play important roles in 
membrane destabilization, which could explain the successfully applications of such 
liposomes. However cytosolic release is not the main fate of delivered moieties in most 
applications of cationic liposomes, as exemplified above. It is important to note that 
lipofection delivery is not based on encapsulation; it is rather based on electrostatic 
interactions with negatively-charged cargos. 
2.2. Quantum dots as probes in other bioassays 
An increasing interest in using QDs as more than passive/active labels is reflected by the 
great number of published data in the literature in the past decade. There is a growing 
research community that recognizes that the fluorescent QDs may be extensively applied as 
a central component of nano-probes (Algar & Krull, 2008). We may classify among all the 
suggested applications the following: Fluorescence Resonance Energy Transfer (FRET) for 
bioassays, optical biosensors and Photodynamic Therapy (PDT). 
In all these applications, the QDs act as scaffolds for the assembly of biomolecular probes 
while its fluorescence is modulated by biorecognition events. In the particular case of FRET-
QDs studies, a broad absorption band combined with a size-tunable fluorescence and larger 
physical size (when compared to conventional dyes) allow: (i) optimization of the spectral 
overlap with any potential FRET acceptor; (ii) excitation at a wavelength far from the 
acceptor absorption peak (minimizing acceptor direct excitation); QDs can be excited over a 
range of wavelengths in the blue-ultraviolet region of the spectrum to allow minimization of 
the direct excitation of acceptors and (iii) the ability to assemble multiple acceptors around a 
QD core to increase the overall FRET efficiency (Algar & Krull, 2008; Bakalova et al., 2004; 
Juzenasa et al., 2008; Medintz & Mattoussi, 2009; Tekdas et al., 2012). The use of fluorescence 
resonance energy transfer (FRET) as a mechanism of tuning QDs’ fluorescence is 
particularly advantageous and due to their high photostability QDs are ideal donors (Algar 
& Krull, 2008; Bakalova et al., 2004; Medintz & Mattoussi, 2009). Moreover, the potentially 
high quantum yield of QDs helps to maximize Förster distances, while the narrow emission 
can be tuned to optimize spectral overlap and reduce crosstalk between donor and acceptor 
(Algar & Krull, 2008; Medintz & Mattoussi, 2009).  
The great potential of FRET-QDs applications may be exemplified by several reports. For 
instance, Stringer et al. developed a biosensor that is able to detect troponin I to diagnose 
early injuries of cardiac muscles (Stringer et al., 2008) and also to detect small amounts of 
nitrated ceruloplasmin (a significant biomarker for cardiovascular disease, lung cancer, and 
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stress response to smoking) (Pyo & Yoo, 2012). Another interesting application is described 
by Krull et al. which performed solid-phase hybridization assays aiming multiplexed nucleic 
acid diagnostics using QDs as donors in FRET processes (Algar & Krull, 2008; Medintz & 
Mattoussi, 2009). They developed multiplexed assays using immobilized QDs as both FRET 
donors and scaffolds for the immobilization of oligonucleotides probes, where the 
association of fluorescent acceptor dyes with sequence-specific hybridization events 
provided the basis for transduction. QD donors were paired with one or more acceptor 
dyes, and the ratios of QD fluorescence and FRET-sensitized acceptor fluorescence provided 
an analytical signal. The basic idea is depicted in Figure 10. 
 
Figure 10. Schematic representation of a FRET process. Immobilized QDs are derivatized with dithiol-
terminated probe oligonucleotides and under light excitation the QDs are envolved in the emission of 
the Alexa Fluor 647 dye bound to a determined oligonucleotides sequence (Algar & Krull, 2008; 
Medintz & Mattoussi, 2009). 
QDs may also play a critical role as energy acceptors in bioluminescence resonance energy 
transfer (BRET) processes, with a bioluminescent protein as the energy donor. BRET 
resembles FRET in many aspects except that it does not require external light source for the 
donor excitation. The broad excitation spectra and large Stokes shift of QDs allow them to be 
excited by nearly all the bioluminescent proteins in BRET assemblies. Feasibility of QDs as 
the BRET acceptor for a mutant of Renilla luciferase (Luc8 with improved chemical stability 
and light efficiency) has been recently realized both in vitro and in vivo (Samia et al., 2006). 
More recently QDs have also been applied in photodynamic therapy (PDT) related 
processes (Juzenasa et al., 2008). This could be done due to the combination of the unique 
optical properties of these nanostructured systems with their active chemical surfaces. PDT  
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Figure 11. Schematic representation of BRET-QDs sensor applied to detect protease activity. In this 
assembly QD and luciferase protein are closely linked together through a peptide substrate. In process 
(A) QD fluorescence induced by the BRET process is observed and in the presence of a protease (B) the 
BRET process is disrupted leading to a loss of bioluminescence-induced QD emission (Xia & Rao, 2009). 
causes cell death (by necrosis or apoptosis) when singlet oxygen and other reactive species 
of oxygen (ROS) are produced while photosensitizers are stimulated by light. In PDT studies 
QDs may work as energy donors for traditional photosensitizers or interacting directly with 
molecular oxygen by mechanisms of energy transfers to generate singlet oxygen as 
described in Figure 12. PDT based QDs have been used both for treatment of skin lesions 
and for the treatment of skin cancers (Xia & Rao, 2009). QDs conjugated with Pc4, a known 
photosensitizing protein, were excited at 488 nm and by energy transfer mechanisms the 
protein was excited indirectly, emitting at 680 nm. In other words, the QDs, when excited, 
emit in a wavelength which excites the protein (Xia & Rao, 2009). 
3. Some drawbacks of quantum dots  
Non-specific interactions are a common phenomenon on the application of biological 
probes. Besides some benefits, these interactions are commonly a negative feature. An 
incomplete conjugation may result in residual non-conjugated QDs in the same colloidal 
suspension which can bind or interact non-specifically with the biological system and 
interfere in the desired results interfering in the specificity of the original applications.  
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Figure 12. The basic process in the production of ROS species in cell PDT using QDs as producers of O2-. 
The most common strategy to overcome non-specific labelling relies in covering the QDs 
surface with polar polymer molecules, such as polyethylene glycol (PEG). This is because 
such polymers are biologically “inert” and hinder electrostatic interactions of nanoparticle 
surface against cell surface or molecules in suspension Pegylated nanoparticles are therefore 
less prone to aggregation (that is, much more stable) and virtually binding-free. Moreover, 
they can allow further conjugation with functional biomolecules, include proteins and 
antibodies (Hezinger et al., 2007; Medintz et al., 2005). Pegylated bioconjugated QDs are then 
able to bind specifically their targets, being stable and virtually free of non-specific 
interactions. Pegylation, however, is not universally inert. We have demonstrated that PEG-
coated CdS/Cd(OH)2 QDs are able to bind live parasites cells, triggering endocytosis by 
specialized endocytic pathways such as those using the flagellar pocket (Chaves et al., 2008).  
Understanding the interactions of nanoparticles and biological specimens, specially cells, is 
of great interest since one can therefore modulate specific cellular processes. Unrestricted 
interactions of any kind of materials, including QDs, have the potential to be toxic, 
especially at higher concentration and/or with enhanced adsorption/internalization. Beyond 
the changes over cell function, more evident effects are prone to be caused by QDs, 
including cellular ones such: (i) changes in cell morphology (Chang et al., 2009), (ii) oxidative 
stress (Lovrić, et al., 2005), (iii) release of heavy metal compounds (Kirchner et al., 2005) and 
(iv) genetic and epigenetic damage (Choi et al., 2008), as well as local inflammation in live 
rats, as we have recently reported. 
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4. General conclusions 
QDs have broad and strong one-photon absorption, narrow and symmetric size-tunable 
fluorescence bands, and a great resistance to photobleaching, making them an attractive 
alternative to molecular fluorophores in imaging applications and bioanalytical chemistry 
assays. This Chapter discusses some current applications of QDs as well as presents some 
drawbacks that still remain. Taken together, all these findings show that a deeper 
understanding of the mechanisms underlying QDs-biological systems interactions is helpful 
in the way that researchers can avoid side effects and improve the quality of labeling of QDs 
for diagnostics and therapeutic purposes. 
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